Affordable Access

Methanol extract of Cordyceps pruinosa inhibits in vitro and in vivo inflammatory mediators by suppressing NF-kappaB activation.

Authors
  • Kim, Ki-Mo
  • Kwon, Young-Guen
  • Chung, Hun-Taeg
  • Yun, Young-Gab
  • Pae, Hyun-Ock
  • Han, Jeong A
  • Ha, Kwon Soo
  • Kim, Tae-Woong
  • Kim, Young-Myeong
Type
Published Article
Journal
Toxicology and applied pharmacology
Publication Date
Jul 01, 2003
Volume
190
Issue
1
Pages
1–8
Identifiers
PMID: 12831777
Source
Medline
License
Unknown

Abstract

Cordyceps pruinosa has been used in traditional folk medicine to treat numerous diseases. The molecular mechanism of C. pruinosa pharmacological and biochemical actions of macrophages in inflammation has not been clearly elucidated. We examined how the methanol extract of C. pruinosa regulates production of IL-1beta, TNF-alpha, nitric oxide (NO), and prostaglandin E(2) (PGE(2)) in vitro and in vivo. The extract inhibits these inflammatory mediators in LPS-stimulated murine macrophage cell line RAW264.7 and primary macrophages, by suppressing gene expression of IL-1beta, TNF-alpha, inducible nitric oxide synthase, and cyclooxygenase-2. Moreover, the extract suppresses the nuclear transcription factor NF-kappaB activation in LPS-stimulated RAW264.7 cells. Administration of the extract significantly decreases the plasma levels of these inflammatory mediators in LPS-injected mice. These results suggest that the C. pruinosa methanol extract suppresses inflammation through suppression of NF-kappaB-dependent inflammatory gene expression, suggesting that the C. pruinosa extract may be beneficial for treatment of endotoxin shock or sepsis.

Report this publication

Statistics

Seen <100 times